Epstein-Barr Virus
Image generated by AI
Researchers explore role of co-infections in long COVID symptoms
Reported by AI Image generated by AI Fact checked
A team of microbiologists suggests that infections occurring alongside SARS-CoV-2 may contribute to some cases of long COVID, potentially by reactivating latent pathogens such as Epstein–Barr virus or altering the course of tuberculosis. Their perspective, published in eLife, stresses that this remains a hypothesis and calls for large studies and better animal models to test whether these co-infections help drive persistent symptoms like fatigue and brain fog.
New research suggests that antivirals targeting the Epstein-Barr virus could offer an effective therapy for multiple sclerosis with fewer side effects than current immune-suppressing drugs.